FDA Approves Sagent Pharmaceuticals’ Orphenadrine Citrate Injection, USP
SCHAUMBURG, Ill., Aug. 31, 2011 (CRWENewswire) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a specialty pharmaceutical company, today announced U.S. FDA approval of its Orphenadrine Citrate Injec... [Read more]



